drugset / Trial / NCT01118624
Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy (ability to provide a beneficial treatment of the disease) of pralatrexate for the treatment of female patients with advanced or metastatic breast cancer who have failed prior chemotherapy. Patients will receive vitamin B12 and folic acid supplementation.
Timeline
- Start
- 2010-03
- Primary completion
- 2012-04
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pralatrexate | Other / unclassified | 190 mg/m2 | Intravenous |